when do you feel retatrutide How Does Work? Doctor Explains Why It's So Effective What Patients Should Understand Before

Always consult your healthcare provider before starting any weight-loss medication

Phase 2 clinical trials of retatrutide, including the landmark studies published in the New England Journal of Medicine in 2023, primarily evaluated the drug's efficacy and safety in terms of weight reduction, cardiovascular markers, and gastrointestinal tolerability

Participants receiving the highest doses achieved up to 24.2% mean body weight reduction over 48 weeks

Not for human consumption, veterinary use, or clinical application

Consent to participate Not applicable

The CVOT results for the oral version of semaglutide (Rybelsus) are pending, with results expected soon